MAINSAIL_2B | R Documentation |
Kaplan-Meier digitized data from MAINSAIL, figure 2B (PMID 25743937). A reported sample size of 1,059 for a primary endpoint of OS in prostate cancer.
MAINSAIL_2B
A data frame of 1,059 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (lenolidomide, placebo) | |
Petrylak DP, Vogelzang NJ, Budnik N, et al. Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Oncol 2015; 16: 417–25.
summary(MAINSAIL_2B)
kmplot(MAINSAIL_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.